In particular, stage II was accompanied by higher levels of PD-L1 expression, which may be induced by cytokines and reflect the contribution of an endogenous anti-tumor immune response, as it generally occurs in the early stages of carcinoma progression [51,52]. The gene discussed is CD274; the disease is carcinoma.